IONEXCHANG - Ion Exchange (India) Ltd Share Price

Management provided an optimistic outlook for Ion Exchange (India) Limited following the Q3 FY 2025-26 results, noting an increase in operational income to INR 7,344 million for the quarter, which is up 6% year-over-year. For the first nine months, operating income grew 8% to INR 20,516 million. However, EBITDA fell 21% year-over-year to INR 593 million, leading to a reduced EBITDA margin of 8.07%. The net profit for the quarter was INR 206 million with a PAT margin of 2.81%.

Key forward-looking points highlighted by management include:

1. Government Support: The management emphasized the Government of India's long-term commitment to infrastructure projects, particularly the continuation of the Jal Jeevan Mission until 2028, which could positively impact Ion Exchange due to the pending projects in this area.

2. Financial Commitment: The Union Budget showed an extended allocation for the Jal Jeevan Mission, potentially enhancing project funding and improving the company's receivables tied to this effort.

3. Sector Opportunities: Management indicated growth prospects in solar and semiconductor projects, with a notable recent win of two domestic solar contracts worth INR 2,050 million.

4. Product Development: The Roha facility's progressive commissioning is expected to ramp up production in the coming months, improving the profit margins from the chemical segment over the next financial year.

5. Operational Expectations: The company anticipates a gradual improvement in the profitability of the engineering segment as they expect higher order execution in Q4 FY 2025-26 and beyond.

Overall, management is cautiously optimistic about leveraging upcoming opportunities while addressing current challenges.

1. Question: "During the quarter, the gross margin has declined 200 bps, and employee costs have increased. What are the reasons for this and have there been one-offs in these expenses?"

   Answer: "Yes, the gross margin decline is due to headwinds in both engineering and chemical segments. We faced issues like funding slowdowns in UP Jal Jeevan Mission projects and an adverse project mix affecting execution. Furthermore, the Roha facility incurred depreciation and interest costs, alongside rupee depreciation impacting input costs. Some of these aspects are temporary, but they affected our margins this quarter."

2. Question: "What was the total CAPEX done for Roha, and how much is capitalized and left in CWIP?"

   Answer: "The total CAPEX for the Roha facility is around INR 450 crores, with INR 285 crores already capitalized. We secured a long-term loan of INR 345 crores to finance this project. Additionally, approximately INR 130 crores remains in capital work in progress (CWIP)."

3. Question: "In Q2, you guided for better execution in the engineering segments, but the actual numbers remain under pressure. What explains the gap between guidance and actual performance?"

   Answer: "The expectations for better performance were based on earlier international projects, but proper invoicing was delayed, making it a timing issue. We anticipate invoicing in the upcoming quarter. Funding delays in the UP Jal Jeevan Mission also contributed to the slowdown in revenue."

4. Question: "Regarding the Roha facility, can you share expected revenues and margins as it ramps up?"

   Answer: "While we cannot disclose specific revenue figures, we estimate that the facility's margin profile will improve once fully commissioned. Currently, we expect a gradual ramp-up in production over four years, and as we stabilize operations, we anticipate achieving margins similar or better than our current facility."

5. Question: "Have you received any orders related to the semiconductor opportunity you previously mentioned?"

   Answer: "We've participated in two semiconductor projects but didn't proceed due to unfavorable pricing. We continue to bid selectively, and we've seen opportunities in both ultra-pure water and wastewater management. We have historical expertise in this area, which strengthens our capability to pursue such projects."

6. Question: "Can you provide insights into how you evaluate projects to avoid unprofitable engagements?"

   Answer: "We employ a robust review mechanism. Key factors include project profitability, customer creditworthiness, cash flow profiles, and the risks associated with the project. We have become increasingly selective based on past experiences, ensuring we only engage in projects that align with our profitability standards."

7. Question: "What are the expected financial implications of the government's Jal Jeevan Mission budget increases on your order intake?"

   Answer: "The government's renewed commitment to the Jal Jeevan Mission, extending funding to 2028, should enhance our cash flows and receivable recovery, leading to improved order intake. While current receivables remain an issue, the increased budget should stimulate disbursements that benefit our pending projects."

8. Question: "Given the challenges you are facing in the legacy projects and the chemical margin pressures, should investors expect lower profitability moving forward, particularly for FY'27?"

   Answer: "While legacy project impacts will still be felt, we expect to improve profitability as we execute our current orders and stabilize operations at Roha. By focusing on enhancing order selection and managing costs, we aim to mitigate profitability declines, although it may take time for substantial recovery."